Synaptogenix, Inc. (SNPX)
NASDAQ: SNPX · IEX Real-Time Price · USD
0.191
-0.008 (-3.79%)
At close: Mar 27, 2024, 4:00 PM
0.200
+0.009 (4.88%)
After-hours: Mar 27, 2024, 7:33 PM EDT

Synaptogenix Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018
Selling, General & Admin
9.818.288.099.844.05
Research & Development
6.324.343.075.674.89
Other Operating Expenses
00002.22
Operating Expenses
16.1312.6211.1615.5111.15
Operating Income
-16.13-12.62-11.16-15.51-11.15
Other Expense / Income
-10.56-0.011.55-0.38-0.13
Pretax Income
-5.57-12.61-12.7-15.13-11.02
Net Income
-5.57-12.61-12.7-15.13-11.02
Preferred Dividends
0.1202.4300
Net Income Common
-5.69-12.61-15.13-15.13-11.02
Shares Outstanding (Basic)
75112
Shares Outstanding (Diluted)
75112
Shares Change
39.36%298.79%--37.52%-
EPS (Basic)
-0.81-2.51-12.03-12.04-5.48
EPS (Diluted)
-0.81-2.51-12.03-12.04-5.48
Free Cash Flow
-11.22-8.71-8.11-11.89-7.7
Free Cash Flow Per Share
-1.60-1.74-6.45-9.46-3.83
EBITDA
-5.57-12.61-12.7-15.13-11.02
Depreciation & Amortization
0.010000
EBIT
-5.57-12.61-12.7-15.13-11.02
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).